Drug | Number studies | Isolates screened (N) | Resistant isolates N (%) | χ2 | P-value |
---|---|---|---|---|---|
Augmentin | 1 | 274 | 154 (56.2) | Â | Â |
Cefepime | 1 | 106 | 67 (63.2) | 0.937 | 0.3331 |
Streptomycin | 1 | 50 | 50 (100.0) | 32.558 |  < 0.0001 |
Cefuroxime | 1 | 75 | 75 (100.0) | 46.363 |  < 0.0001 |
Nalidixic acid | 1 | 20 | 17 (85.0) | 5.221 | 0.0223 |
Co-trimoxazole | 1 | 45 | 45 (100.0) | 29.667 |  < 0.0001 |
Amoxicillin | 1 | 34 | 34 (100.0) | 23.101 |  < 0.0001 |
Methicillin | 1 | 20 | 16 (80.0) | 3.360 | 0.0668 |
Vancomycin | 1 | 32 | 17 (53.1) | 0.0593 | 0.8076 |
Penicillin | 1 | 60 | 60 (100.0) | 38.197 |  < 0.0001 |
Drug class | |||||
Glycopeptides | 1 | 32 | 17 (53.1) | Â | Â |
2nd generation Cephalosporins | 1 | 75 | 75 (100.0) | 38.094 |  < 0.0001 |
4th generation Cephalosporins | 1 | 106 | 67 (63.2) | 0.575 | 0.4481 |
Aminoglycosides | 1 | 50 | 50 (100.0) | 26.220 |  < 0.0001 |
Quinolones | 1 | 20 | 17 (85.0) | 3.928 | 0.0475 |
Sulfonamides | 1 | 45 | 45 (100.0) | 23.829 |  < 0.0001 |
β-lactam + β-lactamase inhibitor | 1 | 274 | 274 (100.0) | 131.672 |  < 0.0001 |